Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company.
Separately, Stephens reaffirmed an “overweight” rating and issued a $38.00 target price on shares of Stevanato Group in a report on Monday, March 25th.
View Our Latest Report on Stevanato Group
Institutional Investors Weigh In On Stevanato Group
Stevanato Group Stock Down 1.6 %
STVN stock opened at €28.40 ($30.21) on Friday. Stevanato Group has a 1 year low of €23.00 ($24.47) and a 1 year high of €36.30 ($38.62). The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50. The stock’s fifty day moving average price is €30.64 and its 200-day moving average price is €29.58.
Stevanato Group (NYSE:STVN – Get Free Report) last released its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The firm had revenue of €320.60 million during the quarter, compared to analysts’ expectations of €326.85 million. During the same quarter last year, the business earned $0.19 earnings per share. The business’s quarterly revenue was up 9.8% on a year-over-year basis. Equities analysts anticipate that Stevanato Group will post 0.67 earnings per share for the current year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- How to Choose Top Rated Stocks
- Comprehensive PepsiCo Stock Analysis
- Are Penny Stocks a Good Fit for Your Portfolio?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.